APO-Perindopril Arginine/Amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/10 perindopril arginine 5 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Binding Site Group Freelite™ Human Kappa Free Kits and Freelite™ Human Lambda Free Kits Singapore - English - HSA (Health Sciences Authority)

binding site group freelite™ human kappa free kits and freelite™ human lambda free kits

the binding site pte. ltd. - immunology - they are intended for the quantitation of kappa free light chains and lambda free light chains respctively in serum and urine samples on the designated analyzers. measurement of free light chains aids in the diagnosis and monitoring of multiple myeloma, lymphocytic neoplasms, waldenström’s macroglobulinemia, al amyloidosis, light chain deposition disease and connective tissue diseases such as systemic lupus erythematosus in conjunction with other laboratory and clinical findings.

GENTA SWIFT-D 10ML E/E DPS India - English - Central Drugs Standard Control Organization

genta swift-d 10ml e/e dps

ind-swift - dexamethasone sod.phos.,gentamicin,phenyl mercuric nitrate - e/e dps - 0.01,0.3,0.001;%w/v - 10ml

SLINDA drospirenone 4 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

slinda drospirenone 4 mg tablet blister pack

besins healthcare australia pty ltd - drospirenone, quantity: 4 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; triacetin; polysorbate 80; titanium dioxide; indigo carmine aluminium lake; iron oxide yellow - contraception

ALDI BUNNYBAIT OAT BAIT FOR RABBITS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aldi bunnybait oat bait for rabbits

aldi gc pty ltd - pindone as sodium salt - bait - pindone as sodium salt benzene-salt active 0.5 g/kg - vertebrate poison - agricultural/farm buildings | closely settled area | farm | urban area | animal housing | in and around | suburb - rabbit

APO-PERINDOPRIL perindopril erbumine 8mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril perindopril erbumine 8mg tablets blister pack

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

APO-PERINDOPRIL perindopril erbumine 4mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril perindopril erbumine 4mg tablets blister pack

arrotex pharmaceuticals pty ltd - perindopril erbumine, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.